ALSO NOTED: Canadian regulators warn on impotence drugs; ZARS wins FDA OK; MAP, Elan expand collaboration; and much more...

> Canadian regulators warn of potential vision problems from impotence drugs. Story

> ZARS nabs its first FDA approval for one of its products, the Synera anesthetic patch. Release

> MAP Pharmaceuticals and Elan have expanded their collaboration. Release

> FDA chief, critics clash in House hearings over agency budget. Story

> FDA taps Pfizer to pull Zyvox ad from professional journal. Report

> Swiss manufacturer Lonza sees first-half earnings raised by biopharma unit. Story

> Testosterone patch boosts women's drive but FDA still wants safety data. Report

> AutoGenomics, Targeted Molecular Diagnostics strike development partnership to identify cancer biomarkers to be used for personalized treatments. Release

> Geron starts testing its lead anti-cancer compound with two Phase I/II clinical trials. Release

> Chinese drug maker to supply ingredients to makers of generic anti-AIDS drugs to be distributed by Clinton Foundation in Africa and Asia. Report

And Finally... Giveaway program, advertising guidelines improve drug industry's tarnished image. Feature